Last reviewed · How we verify

NCT06618209

Assessment of Oral Health Status of Children With Primary Ciliary Dyskinesia

Completed Last updated 1 October 2024
What this trial tests

trial testing physical and chemical methods in Primary Ciliary Dyskinesia in 160 participants. Completed in 1 March 2024.

Timeline
12 June 2023
Primary endpoint
20 August 2023
1 March 2024

Quick facts

Lead sponsorMarmara University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment160
Start date12 June 2023
Primary completion20 August 2023
Estimated completion1 March 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Marmara University

Who can join

Adults 6 to 17, any sex, with Primary Ciliary Dyskinesia or Caries,Dental. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to compare the oral health findings, salivary parameters and pediatric oral health related quality of life of children with Primary Ciliary Dyskinesia (PCD) with healthy children

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Oral Health Status and Oral Health-Related Quality of Life in Children With Primary Ciliary Dyskinesia.
    Oztuna EK, Peker S, Eralp EE, Gokdemir Y, et al · · 2025 · PMID 41221835 · DOI 10.1002/ppul.71370

Verify or expand the search:

Other trials of physical and chemical methods

Trials testing the same drug.

Other recruiting trials for Primary Ciliary Dyskinesia

Currently open trials in the same condition.

Other Marmara University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06618209.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing